medigraphic.com
ISSN 0185-3325 (Print)
Órgano Oficial del Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz

2003, Number 5

<< Back Next >>

Salud Mental 2003; 26 (5)

Avances recientes en la investigación de los mecanismos celulares de acción de los disolventes de abuso.

Páez-Martínez N, López-Rubalcava C, Cruz SL

Language: Spanish
References: 57
Page: 43-50
PDF size: 222.08 Kb.


ABSTRACT

The intentional exposure to volatile organic solvents in order to achieve a state of intoxication constitutes a health problem throughout the world, which mainly affects children and adolescents. In spite of its importance, the study of the molecular mechanisms of action of abused solvents was not addressed until lately. This paper reviews some of the relevant recent advances in this field.
During the last three decades, behavioral studies have provided evidence that solvents have similar effects on the central nervous system as depressant drugs such as ethanol, barbiturates and benzodiazepines. Based on this evidence, it was first hypothesized that abused solvents could share some of the cellular mechanisms of action of other depressant drugs. Using recombinant receptors expressed in Xenopus oocytes and the two-electrode voltage clamp technique, Cruz et al. studied the effects of several commonly abused solvents on the cationic currents elicited through glutamatergic receptors. These studies showed that toluene produces a non-competitive, rapid, complete and reversible inhibition of NMDA receptor ion currents. The NR1/2B NMDA receptor subtype is more sensitive than the NR1/2A and NR1/2C subtypes. The inhibitory concentration at 50% (IC50) for toluene on NR1/2B receptors is 0.17 mM. At the same range of concentrations, toluene has no effect on non–NMDA (AMPA and kainate) receptors. These findings were soon extended to 1,1,1, trichloroethane (TCE) and a series of alkylbenzenes (benzene, m-xylene, ethylbenzene and propylbenzene), all of which were found to inhibit NMDA-induced currents in a dosedependent manner, at sub-millimolar concentrations. Interestingly, flurothyl, a convulsive solvent with physicochemical properties similar to those of many abused solvents (high lipophilicity and volatility), has no effect on glutamatergic receptors. It is worth noting that the range of solvent concentrations tested in these studies does not affect the stability of cellular membranes. Taken together, these findings strongly suggested a specificity of action for abused solvents, which encouraged further research on the effects of these compounds at other neurotransmitter receptors. Thus, in 2000, Beckstead and coworkers studied the effects of toluene, TCE and trichloroethylene on the ionic currents mediated by GABAA and glycine receptors in Xenopus oocytes. They found out that all three solvents increase these currents at 0.2 – 0.9 mM, acting as allosteric modulators of these channels. More recently, Bale et al. showed that toluene has also inhibitory effects on different cholinergic nicotinic receptor subtypes in vitro, the most sensitive of which is the α4Β2 receptor subtype (toluene’s IC50 = 0.2 mM). Moreover, in cultured neuronal cells, toluene inhibits the calcium response to acetylcholine with an IC50 = 0.5 mM. In a recent paper, Lopreato and coworkers reported that toluene, TCE and trichloroethylene increase the ionic currents activated by serotonin through 5-HT3 receptors at concentrations lower than 1 mM. All these effects occur at a range of concentrations that does not compromise the integrity of cell membranes and that is relevant to human exposure to solvents during intoxication. The actions of abused solvents on voltagegated ion channels have also been a focus of attention in the last few years. According to Tillar et al., toluene inhibits Ca2+ currents in KCl-depolarized pheochromocytoma cells, but other authors have found that toluene might activate these channels. Another solvent, TCE, reduces Ca2+ currents in dorsal root ganglion cells, although this effect is only seen at relatively high concentrations (IC50 = 4-6 mM). In a recent report, our group showed that toluene blocks human cardiac sodium channels transfected into Xenopus oocytes. This effect occurs at micromolar concentrations and depends on the dose and on the frequency of stimulation of the channel. The so far described mechanisms of action of solvents are similar to those described for alcohol. A comparison of the potencies of toluene and ethanol to produce similar effects reveals that toluene is, in general, 10-1000 times more potent than ethanol. In the last years an increasing interest has emerged on the effects of abused solvents in the mesolimbic dopaminergic system. According to several researches toluene, like other drugs of abuse, increases dopamine release in selected brain areas. Finally, the formation of free radicals has been proposed as a mechanism that might be involved in the harmful chronic effects of solvents, such as neurotoxicity. In summary, basic research on the cellular effects of solvents has experienced an important increase in the last decade. As a result, it is now clear that these substances do not act through a non-specific membrane fluidization as it was once proposed, but through interactions with several receptor systems at sub-millimolar concentrations.


REFERENCES

  1. ABBOTT A: Neurobiological perspectives on drugs of abuse. Trends Pharmacol Sci, 13:169, 1992.

  2. AGUAYO LG, TAPIA JC, PANCETTI FC: Potentiation of the glycine-activated Cl- current by ethanol in cultured mouse spinal neurons. J Pharmacol Exp Ther, 279:1116-1122, 1996.

  3. AISTRUP GL, MARSZALEC W, NARAHASHI T: Ethanol modulation of nicotinic acetylcholine receptor currents in cultured cortical neurons. Mol Pharmacol, 55:39-49, 1999.

  4. ALLAN AM, HARRIS RA: Gamma-aminobutyric acid and alcohol actions: neurochemical studies of long sleep and short sleep mice. Life Sci, 39:2005-2015, 1986.

  5. ASTON-JONES GS, SIGGINS GR: Electrophysiology. En: Psychopharmacology the Fourth Generation of Progress. Bloom FE, Kupfer DJ (eds). Raven Press, Nueva York, 1995.

  6. AYRES PH, TAYLOR DW: Solvents. En: Principles and Methods of Toxicology. Segunda Edición. Hayes W (ed). Raven Pres, Ltd., Nueva York, 1989.

  7. BALE AS, SMOTHERS CT, WOODWARD JJ: Inhibition of neuronal nicotinic acetylcholine receptors by the abused solvent, toluene. Br J Pharmacol, 137:375-383, 2002.

  8. BECKSTEAD MJ, WEINER JL, EGER EI, GONG DH, MIHIC SJ: Glycine and γ-aminobutyric acidA receptor function is enhanced by inhaled drugs of abuse. Mol Pharmacol, 57:1199-1205, 2000.

  9. BENIGNUS VA, MULLER KE, BARTON CN, BITTILOFER JA: Toluene levels in blood and brain of rats during and after respiratory exposure. Toxicol App Pharmacol, 61:326- 334, 1981.

  10. BUCK KJ, ALLAN AM, HARRIS RA: Fluidization of brain membranes by A2C does not produce anaesthesia and does not augment muscimol stimulated 36Cl- influx. Eur J Pharmacol, 160:359-367, 1989.

  11. CARDOSO RA, BROZOWSKI SJ, CHAVEZ-NORIEGA LE, HARPOLD M, VALENZUELA CF, HARRIS RA: Effects of ethanol on recombinant human neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes. J Pharmacol Exp Ther, 289:774-80, 1999.

  12. CELENTANO JJ, GIBBS TT, FARB DH: Ethanol potentiates GABA- and glycine-induced chloride current in chick spinal cord neurons. Brain Res, 455:377-380, 1988.

  13. COVARRUBIAS M, VYAS TB, ESCOBAR L, WEI A: Alcohols inhibit a cloned potassium channel at a discrete saturable site. J Biol Chem, 270:19408-19416, 1995.

  14. CRUZ SL, MIRSHAHI T, THOMAS B, BALSTER RL, WOODWARD JJ: Effects of the abused solvent toluene on recombinant N-Methyl-D-Aspartate and non-N-Methyl-DAspartate receptors expressed in Xenopus oocytes. J Pharmacol Exp Ther, 286:334-340, 1998.

  15. CRUZ SL, BALSTER RL, WOODWARD JJ: Effects of volatile solvents on recombinant N-methyl-D-aspartate receptors expressed in Xenopus oocytes. Br J Pharmacol, 131:1303-1308, 2000.

  16. DINWIDDIE SH: Abuse of inhalants: a review. Addiction, 89:925-939, 1994.

  17. DREIEM A, MYHRE O, FONNUM F: Relationship between lipophilicity of C6-C10 hydrocarbon solvents and their ROS-inducing potency in rat cerebellar granule cells. Neurotoxicology, 23:701-709, 2002.

  18. EVANS EB, BALSTER RL: CNS. Depressant effects of volatile organic solvents. Neurosci Biobehav Rev, 15:233-241, 1991.

  19. FLANAGAN RJ: Volatile solvent abuse. Bull Narcotics 46:49- 78, 1994.

  20. FRANKS NP, LIEB WR: Mapping of general anaesthetic target sites provides a molecular basis for cutoff effects. Nature, 316:349-351, 1985.

  21. GAUTHEREAU MY, CRUZ SL, ORTA-SALAZAR G, MILLAN-PEREZ-PEÑA L, SALINAS-STEFANON E: Toluene inhibits sodium currents from human cardiac sodium channels transfected into Xenopus laevis oocytes. Drug Alcohol Depend (en prensa).

  22. GERASIMOV MR, SCHIFFER WK, MARSTELLAR D, FERRIERI R, ALEXOFF D, DEWEY SL: Toluene inhalation produces regionally specific changes in extracellular dopamine. Drug Alcohol Depend, 65:243-251, 2002.

  23. HARRIS RA, SCHROEDER F: Ethanol and the physical properties of brain membranes: Fluorescence studies. Mol Pharmacol, 20:128-137, 1981.

  24. JOHNSON BA, AIT-DAOUD N: Neuropharmacological treatments for alcoholism: scientific basis and clinical findings. Psychopharmacology, 149:327-344, 2000.

  25. KING MD: Neurological sequelae of toluene abuse. Hum Toxicol, 1:281-287, 1982.

  26. KOZEL N, SLOBODA Z, DE LA ROSA M (eds): Epidemiology of Inhalant Abuse: An International Perspective. NIDA Res. Monograph Series No. 148. Department of Health and Human Services, Rockville, 1995.

  27. LOPREATO GF, PHELAN R, BORGHESE CM, BECKSTEAD MJ, MIHIC SJ: Inhaled drugs of abuse enhance serotonin-3 receptor function. Drug Alcohol Depend, 70:11- 15, 2003.

  28. LOVINGER DM, WHITE G, WEIGHT FF: Ethanol inhibits NMDA-activated ion current in hippocampal neurons. Science, 243:1721-1724, 1989.

  29. LOVINGER DM: Ethanol potentiates ion current mediated by 5-HT3 receptors on neuroblastoma cells and isolated neurons. Alcohol Alcohol Suppl, 1:181-185, 1991.

  30. LOVINGER DM, ZHOU Q: Alcohols potentiate ion current mediated by recombinant 5-HT3RA receptors expressed in a mammalian cell line. Neuropharmacology, 33:1567-1572, 1994.

  31. MA W, SHAFFER KM, PANCRAZIO JJ, SHUGHNESSY JO, STENGER DA, ZHANG L, BARKER JL, MARIC D: Toluene inhibits muscarinic receptor-mediated cytosolic Ca2+responses in neural precursor cells. Neurotoxicology, 23:61-68, 2002.

  32. MACHU TK, HARRIS RA: Alcohols and anesthetics enhance the function of 5-hydroxytryptamine3 receptors expressed in Xenopus laevis oocytes. J Pharmacol Exp Ther, 271:898- 905, 1994.

  33. MASCIA MP, MIHIC SJ, VALENZUELA CF, SCHOFIELD PR, HARRIS RA: A single amino acid determines differences in ethanol actions on strychnine-sensitive glycine receptors. Mol Pharmacol, 50:402-406, 1996.

  34. MATTIA CJ, ADAMS JD Jr, BONDY SC: Free radical induction in the brain and liver by products of toluene catabolism. Biochem Pharmacol, 46:103-110, 1993.

  35. MEREDITH TJ, RUPRAH M, LIDDLE A, FLANAGAN RL: Diagnosis and treatment of acute poisoning with volatile substances. Hum Toxicol, 8:277-286, 1989.

  36. MIHIC SJ, WHITING PJ, HARRIS RA: Anaesthetic concentrations of alcohols potentiate GABAA receptormediated currents: lack of subunit specificity. Eur J Pharmacol, 268:209-214, 1994.

  37. MIRSHAHI T, WOODWARD JJ: Ethanol sensitivity of heteromeric NMDA receptors: effects of subunit assembly, glycine and NMDAR1 Mg(2+)-insensitive mutants. Neuropharmacology, 34:347-355, 1995.

  38. MORTON HG: Occurrence and treatment of solvent abuse in children and adolescents. Pharmacol Ther, 33:449-469, 1987.

  39. 39.MULLIKIN-KILPATRICK D, TREISTMAN SN: Electrophysiological studies on calcium channels in naive and ethanoltreated PC12 cells. Alcohol Alcohol Suppl, 2:385-389, 1993.

  40. MYHRE O, FONNUM F: The effect o aliphatic, naphthenic, and aromatic hydrocarbons on production of reactive oxygen species and reactive nitrogen species in rat brain synaptosome fraction: the involvement of calcium, nitric oxide synthase, mitochondria, and phospholipase A. Biochem Pharmacol, 62:119-128, 2001.

  41. National Institute on Drug Abuse (NIDA): Inhalant Abuse. En: http:www.nida.nih.gov/ResearchReports/Inhalants, 1999.

  42. NESTLER EJ, HYMAN SE, MALENKA RC (eds): Reinforcement and addictive disorders. En: Molecular Neuropharmacology. A Foundation for Clinical Neuroscience. McGraw-Hill Co., 355-382, 2001.

  43. OKUDA M, KUNITSUGU I, KOBAYAKAWA S, HOBARA T: Effect of 1,1,1-tricloroethane on calcium current of rat dorsal root ganglion neurons. Bull Environ Contam Toxicol, 67:476-482, 2001.

  44. REA TM, NASH JF, ZABIK JE, BORN GS, KESSLER WV: Effects of toluene inhalation on brain biogenic amines in the rat. Toxicology, 31:143-150, 1984.

  45. RIEGEL AC, FRENCH ED: An electrophysiological analysis of rat ventral tegmental dopamine neuronal activity during acute toluene exposure. Pharmacol Toxicol, 85:37-43, 1999.

  46. STENGARD K, HÖGLUND G, UNGERSTEDT U: Extracellular dopamine levels within the striatum increase during inhalation exposure to toluene. A microdialysis study in awake, freely moving rats. Toxicol Lett, 71:245-255, 1994.

  47. SUZDAK PD, SCHWARTZ RD, SKOLNICK P, PAUL SM: Ethanol stimulates gamma-aminobutyric acid receptormediated chloride transport in rat brain synaptoneurosomes. Proc Natl Acad Sci USA, 83:4071-4075, 1986.

  48. TICKU MK, LOWRIMORE P, LEHOULLIER P: Ethanol enhances GABA-induced 36Cl-influx in primary spinal cord cultured neurons. Brain Res Bull, 17:123-126, 1986.

  49. TILLAR R, SHAFER TJ, WOODWARD JJ: Toluene inhibits voltage-sensitive calcium channels expressed in pheochromocytoma cells. Neurochem Int, 41:391-397, 2002.

  50. WANG X, LEMOS JR, DAYANITHI G, NORDMANN JJ, TREISTMAN SN: Ethanol reduces vasopressin release by inhibiting calcium currents in nerve terminals. Brain Res, 551:339-341, 1991.

  51. WANG X, WANG G, LEMOS JR, TREISTMAN SN: Ethanol directly modulates gating of a dihydropyridine-sensitive Ca2+ channel in neurohypophysial terminals. J Neurosci, 14:5453- 5460, 1994.

  52. WARREN DA, BOWEN SE, JENNINGS WB, DALLAS CE, BALSTER RL: Biphasic effects of 1,1,1-trichloroethane on the locomotor activity of mice: relationship to blood and brain solvent concentrations. Toxicol Sci, 56:365-373, 2000.

  53. WEINER JL, ZHANG L, CARLEN PL: Potentiation of GABAA-mediated synaptic current by ethanol in hippocampal CA1 neurons: possible role of protein kinase C. J Pharmacol Exp Ther, 268:1388-1395, 1994.

  54. WESTERINK RHS, VIJVERBERG HPM: Toluene-induced, Ca2+dependent vesicular catecholamine release in rat PC12 cells. Neurosci Lett, 326:81-84, 2002.

  55. WIRKNER K, EBERTS C, POELCHEN W, ALLGAIER C, ILLES P: Mechanism of inhibition by ethanol of NMDA and AMPA receptor channel functions in cultured rat cortical neurons. Naunyn Schmiedebergs Arch Pharmacol, 362(6):568- 76, 2000.

  56. WOODWARD JJ: Overview of the effects of alcohol on the cerebral nervous system. Neurochem Int, 35:93-94, 1999.

  57. YU D, ZHANG L, EISELE JL, BERTRAND D, CHANGEUX JP, WEIGHT FF: Ethanol inhibition of nicotinic acetylcholine type alpha 7 receptors involves the aminoterminal domain of the receptor. Mol Pharmacol, 50:1010- 1016, 1996.




2020     |     www.medigraphic.com